| Jul 23 |
Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
|
| Jul 23 |
Guardant settles allegations it violated the False Claims Act
|
| Jul 19 |
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
|
| Jul 18 |
Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
|
| Jul 3 |
3 Biotech Moonshots With Imminent Catalyst Potential
|
| Jul 3 |
The 3 Best Personalized Medicine Stocks to Buy in July 2024
|
| Jun 26 |
Guardant Health (GH) Just Overtook the 20-Day Moving Average
|
| Jun 25 |
Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy?
|
| Jun 11 |
Even after rising 7.4% this past week, Guardant Health (NASDAQ:GH) shareholders are still down 74% over the past three years
|
| Jun 6 |
Guardant: Double-Digit Sales Projections Come At A Cost
|
